- Featured Product
- KD/KO Validated
CDK2 Polyclonal antibody
CDK2 Polyclonal Antibody for FC, IF, IHC, IP, WB, ELISA
Cat No : 10122-1-AP
|Positive WB detected in
|HepG2 cells, MCF-7 cells, A431 cells, NIH/3T3 cells, rat kidney tissue, HEK-293 cells, Jurkat cells, K-562 cells, Hela cells
|Positive IP detected in
|Positive IHC detected in
|human liver cancer tissue, human prostate cancer tissue
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
|Positive IF detected in
|HeLa cells, mouse testis tissue
|Positive FC detected in
|Western Blot (WB)
|WB : 1:2000-1:16000
|IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate
|IHC : 1:50-1:500
|IF : 1:50-1:500
|Flow Cytometry (FC)
|FC : 0.40 ug per 10^6 cells in a 100 µl suspension
|It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
|Sample-dependent, check data in validation data gallery
10122-1-AP targets CDK2 in WB, IP, IHC, IF, FC, CoIP, ELISA applications and shows reactivity with human, mouse, rat samples.
|FC, IF, IHC, IP, WB, ELISA
|CoIP, FC, IF, IHC, IP, WB
|human, mouse, rat
|human, mouse, rat, sheep, sea cucumbers, fish, zebrafish
|CDK2 fusion protein Ag0166 种属同源性预测
|Host / Isotype
|Rabbit / IgG
|cyclin-dependent kinase 2
|CDK2, Cell division protein kinase 2, cyclin dependent kinase 2, p33 protein kinase, p33(CDK2)
|Calculated molecular weight
|Observed molecular weight
|GenBank accession number
|Gene ID (NCBI)
|Antigen affinity purification
|PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
|Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.
|Product Specific Protocols
|WB protocol for CDK2 antibody 10122-1-AP
|IHC protocol for CDK2 antibody 10122-1-AP
|IF protocol for CDK2 antibody 10122-1-AP
|IP protocol for CDK2 antibody 10122-1-AP
|Click here to view our Standard Protocols
Signal Transduct Target Ther
SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis
LncRNA TROJAN promotes proliferation and resistance to CDK4/6 inhibitor via CDK2 transcriptional activation in ER+ breast cancer.
Acquired resistance to KRAS G12C small-molecule inhibitors via genetic/nongenetic mechanisms in lung cancer
Polo-like kinase 1 coordinates biosynthesis during cell cycle progression by directly activating pentose phosphate pathway.
J Clin Invest
TALEN-mediated targeting of HPV oncogenes ameliorates HPV-related cervical malignancy.
Whole-exome sequencing of alpha-fetoprotein producing gastric carcinoma reveals genomic profile and therapeutic targets.